NCT01542450 - Pharmacokinetics of Insulin Detemir in Subjects With Type 1 Diabetes | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

February 28, 2003

Study Completion Date

February 28, 2003

Conditions

DiabetesDiabetes Mellitus, Type 1

Interventions

DRUG

insulin detemir

Single dose of 0.3 U/kg administered subcutaneously (s.c. under the skin) in each treatment period separated by a washout period of 4-28 days

DRUG

insulin NPH

Single dose of 0.3 U/kg administered subcutaneously (s.c. under the skin) in each treatment period separated by a washout period of 4-28 days

Trial Locations (1)

Novo Nordisk Investigational Site, Tokyo